Barclays’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$566K Sell
47,388
-2,528
-5% -$30.2K ﹤0.01% 2983
2025
Q1
$593K Sell
49,916
-16,520
-25% -$196K ﹤0.01% 2737
2024
Q4
$1.02M Buy
66,436
+60,762
+1,071% +$935K ﹤0.01% 2625
2024
Q3
$64K Buy
5,674
+1,109
+24% +$12.5K ﹤0.01% 3857
2024
Q2
$25K Sell
4,565
-11,594
-72% -$63.5K ﹤0.01% 3859
2024
Q1
$110K Sell
16,159
-15,365
-49% -$105K ﹤0.01% 3607
2023
Q4
$214K Buy
31,524
+27,417
+668% +$186K ﹤0.01% 3478
2023
Q3
$21K Sell
4,107
-487
-11% -$2.49K ﹤0.01% 3895
2023
Q2
$33K Sell
4,594
-7,225
-61% -$51.9K ﹤0.01% 3841
2023
Q1
$100K Sell
11,819
-1,710
-13% -$14.5K ﹤0.01% 3527
2022
Q4
$115K Buy
13,529
+12,781
+1,709% +$109K ﹤0.01% 3384
2022
Q3
$8K Buy
+748
New +$8K ﹤0.01% 4254
2022
Q2
Sell
-3,093
Closed -$32K 4731
2022
Q1
$32K Buy
+3,093
New +$32K ﹤0.01% 4171